PDCD1LG2 and cancer: The level of PD-L2 was very low in these cells.<h4>Conclusions</h4>Since PD-L1 glycosylation plays an important role in preventing T cells from attacking cancer cells, such DIFs may promote T cell attack on cancer cells <i>in vivo</i>.